Schentag J J, Cumbo T J, Jusko W J, Plaut M E
JAMA. 1978 Nov 3;240(19):2067-9.
In 64 adults treated with gentamicin sulfate, peak and trough serum concentrations rose gradually and declined in two phases after the final dose. Seventeen patients experienced renal damage. The 17 patients had greater amounts of gentamicin in tissues even after the first dose and before any renal effects were noted. This pharmacokinetics analysis provided evidence that patients who experience gentamicin-related nephrotoxic effects while receiving recommended doses of gentamicin could be distinguished from patients with no toxic effects because they experienced abnormal tissue accumulation before detectable changes in renal function occurred.
在64例接受硫酸庆大霉素治疗的成人患者中,末次给药后血清峰浓度和谷浓度逐渐上升,并分两个阶段下降。17例患者出现肾损害。即使在首次给药后且在未观察到任何肾脏效应之前,这17例患者组织中的庆大霉素含量也更高。这项药代动力学分析提供了证据,表明在接受推荐剂量庆大霉素治疗时出现庆大霉素相关肾毒性效应的患者,可与无毒性效应的患者区分开来,因为他们在肾功能出现可检测变化之前就经历了异常的组织蓄积。